Brown Taylor C, Nicolson Norman G, Man Jianliang, Gibson Courtney E, Stenman Adam, Juhlin C Christofer, Korah Reju, Carling Tobias
Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.
Department of Surgery & Yale Endocrine Neoplasia Laboratory, Yale University School of Medicine, New Haven, Connecticut.
J Endocr Soc. 2020 May 25;4(7):bvaa060. doi: 10.1210/jendso/bvaa060. eCollection 2020 Jul 1.
Tumorigenesis requires mitigation of osmotic stress and the transcription factor nuclear factor of activated T cells 5 (NFAT5) coordinates this response by inducing transcellular transport of ions and osmolytes. NFAT5 modulates in vitro behavior in several cancer types, but a potential role of NFAT5 in adrenocortical carcinoma (ACC) has not been studied. A discovery cohort of 28 ACCs was selected for analysis. Coverage depth analysis of whole-exome sequencing reads assessed copy number alterations in 19 ACCs. Quantitative real-time PCR measured mRNA expression levels in 11 ACCs and 23 adrenocortical adenomas. Immunohistochemistry investigated protein expression in representative adrenal samples. The Cancer Genome Atlas database was analyzed to corroborate findings from the discovery cohort and to test whether expression correlated with ion/osmolyte channel and regulatory protein expression patterns in ACC. was amplified in 10 ACCs (52.6%) and clustered in the top 6% of all amplified genes. mRNA expression levels were 5-fold higher compared with adrenocortical adenomas ( < 0.0001) and overexpression had a sensitivity and specificity of 81.8% and 82.7%, respectively, for malignancy. Increased protein expression and nuclear localization occurred in representative ACCs. The Cancer Genome Atlas analysis demonstrated concomitant amplification and overexpression ( < 0.0001) that correlated with increased expression of sodium/myo-inositol transporter ( = 0.237, < 0.0001) and 14 other regulatory proteins ( < 0.05) previously shown to interact with NFAT5. Amplification and overexpression of and associated osmotic stress response related genes may play an important role adrenocortical tumorigenesis.
肿瘤发生需要减轻渗透压应激,而活化T细胞核因子5(NFAT5)转录因子通过诱导离子和渗透溶质的跨细胞转运来协调这一反应。NFAT5调节几种癌症类型的体外行为,但尚未研究NFAT5在肾上腺皮质癌(ACC)中的潜在作用。选择了一个由28例ACC组成的发现队列进行分析。对19例ACC进行全外显子测序读数的覆盖深度分析,评估拷贝数改变。定量实时PCR测量了11例ACC和23例肾上腺皮质腺瘤中的mRNA表达水平。免疫组织化学研究了代表性肾上腺样本中的蛋白质表达。分析了癌症基因组图谱数据库,以证实发现队列的结果,并测试其表达是否与ACC中的离子/渗透溶质通道及调节蛋白表达模式相关。NFAT5在10例ACC(52.6%)中扩增,并聚集在所有扩增基因的前6%。与肾上腺皮质腺瘤相比,mRNA表达水平高5倍(P<0.0001),NFAT5过表达对恶性肿瘤的敏感性和特异性分别为81.8%和82.7%。在代表性ACC中出现蛋白质表达增加和核定位。癌症基因组图谱分析显示NFAT5同时扩增和过表达(P<0.0001),这与钠/肌醇转运体(SLC5A3,r=0.237,P<0.0001)和其他14种先前显示与NFAT5相互作用的调节蛋白表达增加相关(P<0.05)。NFAT5及其相关的渗透压应激反应相关基因的扩增和过表达可能在肾上腺皮质肿瘤发生中起重要作用。